109 related articles for article (PubMed ID: 10670411)
1. Delta-opioid receptor-mediated increase in cortical extracellular levels of cholecystokinin-like material by subchronic morphine in rats.
Becker C; Pohl M; Thiébot MH; Collin E; Hamon M; Cesselin F; Benoliel JJ
Neuropharmacology; 2000 Jan; 39(2):161-71. PubMed ID: 10670411
[TBL] [Abstract][Full Text] [Related]
2. Delta(2)-opioid receptor mediation of morphine-induced CCK release in the frontal cortex of the freely moving rat.
Becker C; Hamon M; Cesselin F; Benoliel JJ
Synapse; 1999 Oct; 34(1):47-54. PubMed ID: 10459171
[TBL] [Abstract][Full Text] [Related]
3. Morphine-induced in vivo release of spinal cholecystokinin is mediated by delta-opioid receptors--effect of peripheral axotomy.
Gustafsson H; Afrah AW; Stiller CO
J Neurochem; 2001 Jul; 78(1):55-63. PubMed ID: 11432973
[TBL] [Abstract][Full Text] [Related]
4. Mu and delta opioid receptors mediate opposite modulations by morphine of the spinal release of cholecystokinin-like material.
Benoliel JJ; Collin E; Mauborgne A; Bourgoin S; Legrand JC; Hamon M; Cesselin F
Brain Res; 1994 Aug; 653(1-2):81-91. PubMed ID: 7982079
[TBL] [Abstract][Full Text] [Related]
5. Implication of delta opioid receptor subtype 2 but not delta opioid receptor subtype 1 in the development of morphine analgesic tolerance in a rat model of chronic inflammatory pain.
Beaudry H; Gendron L; Morón JA
Eur J Neurosci; 2015 Apr; 41(7):901--7. PubMed ID: 25639561
[TBL] [Abstract][Full Text] [Related]
6. [Interactions between central opioidergic and cholecystokininergic systems in rats: possible significance for the development of of opioid tolerance].
Benoliel JJ; Becker C; Mauborgne A; Bourgoin S; Hamon M; Cesselin F
Bull Acad Natl Med; 1998; 182(2):311-24. PubMed ID: 9648346
[TBL] [Abstract][Full Text] [Related]
7. Extracellular cholecystokinin levels in the rat spinal cord following chronic morphine exposure: an in vivo microdialysis study.
Lucas GA; Hoffmann O; Alster P; Wiesenfeld-Hallin Z
Brain Res; 1999 Mar; 821(1):79-86. PubMed ID: 10064790
[TBL] [Abstract][Full Text] [Related]
8. Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists.
Abul-Husn NS; Sutak M; Milne B; Jhamandas K
Br J Pharmacol; 2007 Jul; 151(6):877-87. PubMed ID: 17502848
[TBL] [Abstract][Full Text] [Related]
9. Differential inhibitory/stimulatory modulation of spinal CCK release by mu and delta opioid agonists, and selective blockade of mu-dependent inhibition by kappa receptor stimulation.
Benoliel JJ; Bourgoin S; Mauborgne A; Legrand JC; Hamon M; Cesselin F
Neurosci Lett; 1991 Apr; 124(2):204-7. PubMed ID: 1648690
[TBL] [Abstract][Full Text] [Related]
10. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo.
Collin E; Frechilla D; Pohl M; Bourgoin S; Le Bars D; Hamon M; Cesselin F
Brain Res; 1993 Apr; 609(1-2):211-22. PubMed ID: 8389648
[TBL] [Abstract][Full Text] [Related]
11. Roles of different subtypes of opioid receptors in mediating the ventrolateral orbital cortex opioid-induced inhibition of mirror-neuropathic pain in the rat.
Zhao M; Wang JY; Jia H; Tang JS
Neuroscience; 2007 Feb; 144(4):1486-94. PubMed ID: 17184926
[TBL] [Abstract][Full Text] [Related]
12. Opioid control of the in vitro release of cholecystokinin-like material from the rat substantia nigra.
Benoliel JJ; Mauborgne A; Bourgoin S; Legrand JC; Hamon M; Cesselin F
J Neurochem; 1992 Mar; 58(3):916-22. PubMed ID: 1310726
[TBL] [Abstract][Full Text] [Related]
13. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
14. mu- but not delta- and kappa-opioid receptors in the ventrolateral orbital cortex mediate opioid-induced antiallodynia in a rat neuropathic pain model.
Zhao M; Wang JY; Jia H; Tang JS
Brain Res; 2006 Mar; 1076(1):68-77. PubMed ID: 16476416
[TBL] [Abstract][Full Text] [Related]
15. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
16. Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity.
Mellon RD; Bayer BM
Brain Res; 1998 Apr; 789(1):56-67. PubMed ID: 9602057
[TBL] [Abstract][Full Text] [Related]
17. Inverse agonist action of Leu-enkephalin at delta(2)-opioid receptors mediates spinal antianalgesia.
Rady JJ; Holmes BB; Tseng LF; Fujimoto JM
J Pharmacol Exp Ther; 2001 May; 297(2):582-9. PubMed ID: 11303046
[TBL] [Abstract][Full Text] [Related]
18. Involvement of mu- and delta-opioid receptors in the effects of systemic and locally perfused morphine on extracellular levels of dopamine, DOPAC and HVA in the nucleus accumbens of the halothane-anaesthetized rat.
Borg PJ; Taylor DA
Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):582-8. PubMed ID: 9151296
[TBL] [Abstract][Full Text] [Related]
19. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
20. Prevention by 5-HT1A receptor agonists of restraint stress- and yohimbine-induced release of cholecystokinin in the frontal cortex of the freely moving rat.
Becker C; Hamon M; Benoliel JJ
Neuropharmacology; 1999 Apr; 38(4):525-32. PubMed ID: 10221756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
